• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,408.56
  • 0.49 %
  • $187.93
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
Mural Oncology plc (MURA) Stock Price, News & Analysis

Mural Oncology plc (MURA) Stock Price, News & Analysis

Currency in USD Disclaimer

$3.36

-$0.09

(-2.61%)

Day's range
$3.36
Day's range
$3.49
50-day range
$3
Day's range
$3.92
  • Country: IE
  • ISIN: IE000LK2BOB4
52 wk range
$2.88
Day's range
$6.25
  • CEO: Ms. Caroline J. Loew Ph.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -0.70
  • Piotroski Score 3.00
  • Grade Buy
  • Symbol (MURA)
  • Company Mural Oncology plc
  • Price $3.36
  • Changes Percentage (-2.61%)
  • Change -$0.09
  • Day Low $3.36
  • Day High $3.49
  • Year High $6.25

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 12/12/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $0.00
  • Trailing P/E Ratio N/A
  • Forward P/E Ratio N/A
  • P/E Growth N/A
  • Net Income $-207,447,000

Income Statement

Quarterly

Annual

Latest News of MURA

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Mural Oncology plc Frequently Asked Questions

  • What were the earnings of MURA in the last quarter?

    In the last quarter Mural Oncology plc earnings were on Tuesday, August, 13th. The Mural Oncology plc maker reported -$1.86 EPS for the quarter, beating analysts' consensus estimates of -$1.90 by $0.04.

  • What is the Mural Oncology plc stock price today?

    Today's price of Mural Oncology plc is $3.36 — it has decreased by -2.61% in the past 24 hours. Watch Mural Oncology plc stock price performance more closely on the chart.

  • Does Mural Oncology plc release reports?

    Yes, you can track Mural Oncology plc's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Mural Oncology plc stock forecast?

    Watch the Mural Oncology plc chart and read a more detailed Mural Oncology plc stock forecast to see what analysts suggest you do with its shares.

  • What is Mural Oncology plc stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Mural Oncology plc stock ticker.

  • How to buy Mural Oncology plc stocks?

    Like other stocks, MURA shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Mural Oncology plc's EBITDA?

    Mural Oncology plc measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Mural Oncology plc’s financial statements.

  • What is the Mural Oncology plc's net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Mural Oncology plc stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Mural Oncology plc's financials relevant news, and technical analysis. Mural Oncology plc's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Mural Oncology plc stock currently indicates a “sell” signal. For more insights, review Mural Oncology plc’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.